Details of the Drug

General Information of Drug (ID: DMCGPU8)

Drug Name
SNX281
Indication
Disease Entry ICD 11 Status REF
Lymphoma 2A80-2A86 Phase 1 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
138657983
TTD ID
DUA7N4
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Stimulator of interferon genes protein (TMEM173) TTT402Y STING_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04609579) Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Silicon Therapeutics.